Andrew Redfern

Dr

  • The University of Western Australia (M582), 35 Stirling Highway,

    6009 Perth

    Australia

  • 235 Citations
  • 6 h-Index
20122022
If you made any changes in Pure these will be visible here soon.

Research Output 2012 2019

  • 235 Citations
  • 6 h-Index
  • 18 Article
  • 4 Abstract/Meeting Abstract
  • 2 Review article
Filter
Abstract/Meeting Abstract
2018

Efficacy and Safety of Palbociclib Plus Endocrine Therapy (ET) for HR+/HER2-Advanced Breast Cancer (ABC) in the Asian-Pacific (AP) Region

Im, S-A., Masuda, N., Im, Y-H., Inoue, K., Kim, S-B., Redfern, A., Lombard, J., Lu, D., Theall, K. P., Gauthier, E., Mukai, H. & Ro, J., Aug 2018, In : Asia-Pacific Journal of Clinical Oncology. 14, p. 62-62 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

Loss of SLIRP is associated with poorer prognosis and increased invasion in colorectal cancer

Candy, P. A., Colley, S. M., Phillips, M. R., Redfern, A. D., Wood, B. A. & Leedman, P. J., Jun 2018, In : Clinical Endocrinology. 89, p. 41-41 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2017

Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer

Redfern, A., Lau, P., White, A., Hoon, S., Bulsara, M. & Long, A., Feb 2017, In : Cancer Research. 77, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2016

Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer

Redfern, A., Rashwan, R., Sorolla, A., Ratajska, M., Kardas, I., Kuzniacka, A., Parry, J., Curtis, C., Woo, A., Sgro, A. & Biernat, W., 15 Feb 2016, In : Cancer Research. 76, 2 p.

Research output: Contribution to journalAbstract/Meeting Abstract